Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03027375
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT03027375
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03027375. Randomized; triple masking; primary purpose treatment. Start 2017-03-31 (actual); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
- Condition
- Heart Failure
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Qishen Granules
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing University of Chinese Medicine
- Collaborator
- China-Japan Friendship Hospital
- Collaborator
- Zhengzhou Hospital of Traditional Chinese Medicine
- Collaborator
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct03027375- Content hash
08580729ed63ff5fa7a7046f48796aff72f6c6584e9ee479bf80006d5499dfeb